Spitalul Clinic De Urgenta Pentru Copii Louis Turcanu Timisoara — Clinical Trial Site

19 Registered trials

11 Currently recruiting

Organisation

Spitalul Clinic De Urgenta Pentru Copii Louis Turcanu Timisoara

Location

Timisoara, Romania

Identifier

ORG-100046817

Address

Strada Doctor Iosif Nemoianu 2, 300011, Romania

Departments

#40770: Pediatric Neurology
#561: Centrul de Sănătate Mintală Copii şi Adolescenţi
#577: Paediatrics-Neurology
Emergency Pediatric Hospital "Louis Turcanu"
Oncology-Haematology and BMP department
Paediatric survery and orthopedics
Pediatric Psychiatry
Pediatrics
Pediatrics III
Pediatrics IV - peritoneal dialysis
Pediatrie III
Psychiatry
Sectia Clinica III Pediatrie
Sectia Clinica IV Pediatrie

Clinical trials at this site (19)

Search interface

A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM 201 in Naïve-to-Tr… Not authorised

2025-523820-26-00 Growth Hormone Deficiency (GHD) 5
A Phase 3 Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (13 to 17 years of age) Pending

2025-523711-11-00 Schizophrenia 5
Phase 3 Evaluation of KarXT and KarXT+KarX-EC in Schizophrenia and Autism-Related Irritability in Youth, respectively. Pending

2025-524062-16-00 Schizophrenia and Autism Spectrum Disorder (ASD) 5
A study for adolescents who are depressed and thinking of suicide Recruiting

2024-518615-19-00 Major Depressive Disorder 5 2026-04-22
A study to investigate the efficacy and safety of fitusiran prophylaxis in male participants aged 1 to less than 12 years with hemophilia A … Recruiting

2025-521858-42-00 Hemophilia 5 2026-03-16
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis Recruiting

2024-511458-32-00 Ulcerative colitis 5 2025-06-15
Effect of patiromer in children under 12 years of age with high blood potassium levels Recruiting

2023-505252-21-00 Hyperkalemia 4 2025-02-14
A Phase 3, Open-Label, Uncontrolled Study to Evaluate the Activity, Safety, Pharmacokinetics and Pharmacodynamics of Roxadustat for the Trea… Recruiting

2022-501980-42-00 Anemia associated with Chronic Kidney Disease 5 2023-12-21
Safety and Tolerability of Cariprazine in the Treatment of Adolescent Patients with Schizophrenia Recruiting

2024-513222-30-00 Adolescent patient (13-17 years of age) with Schizophre 5 2020-02-20
A Phase III study to evaluate the efficacy of INM004 (Shiga antitoxin) in pediatric patients with Shiga toxin-producing Escherichia coli-ass… Recruiting

2024-512412-22-00 Hemolytic Uremic Syndrome 5 2025-06-24
An open-label, pharmacokinetic, safety, and efficacy study (Part I, single cycle) and double-blind, efficacy, non inferiority, and safety st… Recruiting

2024-514321-39-00 Chemotherapy-induced nausea and vomiting 10 2025-05-06
A Phase 3 Efficacy and Safety Study of Pitolisant in Patients with Prader-Willi Syndrome Recruiting

2023-508307-21-00 Prader-Willi syndrome 5 2025-03-19
Apremilast Study in Children with Active Juvenile Psoriatic Arthritis Recruiting

2023-503435-17-00 Juvenile psoriatic arthritis 5 2021-03-31
An open-label study to assess safety and efficacy of SZC in paediatric patients with hyperkalaemia Recruiting

2023-508455-38-00 Hyperkalaemia 5 2019-09-12
A study to learn about the safety of long-term treatment with brivaracetam in children and young adults with childhood or juvenile absence e… Ended

2023-508095-11-00 Childhood Absence Epilepsy 5 2024-11-27
A Multicenter, Open-Label, Evaluator-Blinded, Randomized Study to Evaluate the Safety and Tolerability of Single-Dose IV Oritavancin for the… Ended

2024-516385-10-00 Acute Bacterial Skin and Skin Structure Infections 4 2023-05-02
A study to learn if brivaracetam works and is safe in children and young adults 2 to 25 years of age with childhood absence epilepsy or juve… Ended

2023-510428-55-00 Childhood Absence Epilepsy Juvenile Absence Epilepsy 10 2022-03-10
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 years of age) with Schizophrenia Ended

2024-513194-44-00 Adolescent Patients (13 to 17 years of age) with Schizo 5 2021-12-14
A study to learn if lacosamide is safe to take over a long period of time in children with epilepsy Ended

2022-502639-21-00 Epilepsy 5 2020-12-28